Abstract
Objective
To identify differences in the evolution of children with non-severe acute lower respiratory tract infection between those with and without radiographically diagnosed pneumonia.
Design
Prospective cohort study.
Setting
A public university pediatric hospital in Salvador, Northeast Brazil.
Patients
Children aged 2-59 months.
Methods
By active surveillance, the pneumonia cases were prospectively identified in a 2-year period. Each case was followed-up for changes in various clinical symptoms and signs. Demographic, clinical and radiographic data were recorded in standardized forms. Exclusion was due to antibiotic use in the previous 48 hours, signs of severe disease, refusal to give informed consent, underlying chronic illness, hospitalization in the previous 7 days or amoxicillin allergy. Chest X-ray (CXR) was later read by at least 2 independent pediatric radiologists.
Main Outcome Measures
Radiographic diagnosed pneumonia based on agreed detection of pulmonary infiltrate or pleural effusion in 2 assessments.
Results
A total of 382 patients receiving amoxicillin were studied, of whom, 372 (97.4%) had concordant radiographic diagnosis which was pneumonia (52%), normal CXR (41%) and others (7%). By multivariate analysis, age (OR=1.03; 95% CI: 1.02–1.05), disease ≥ 5days (OR = 1.04; 95% CI: 1.001-1.08), reduced pulmonary expansion (OR = 3.3; 95% CI: 1.4–8.0), absence of wheezing (OR = 0.5; 95% CI: 0.3–0.9), crackles on admission (OR = 2.0; 95% CI: 1.2–3.5), inability to drink on day 1 (OR = 4.2; 95% CI: 1.05–17.3), consolidation percussion sign (OR = 7.0; 95% CI: 1.5–32.3), tachypnea (OR = 2.0; 95% CI: 1.09–3.6) and fever (OR = 3.6; 95% CI: 1.4–9.4) on day 2 were independently associated with pneumonia. The highest positive predictive value was at the 2nd day of evolution for tachypnea (71.0%) and fever (81.1%).
Conclusion
Persistence of fever or tachypnea up to the second day of amoxicillin treatment is predictive of radiographically diagnosed pneumonia among children with non-severe lower respiratory tract diseases.
Similar content being viewed by others
References
Ranganathan SC, Sonnappa S. Pneumonia and other respiratory infections. Pediatr Clin North Am. 2009;56:135–156.
World Health Organization. Acute Respiratory Infections in Children: Case Management in Small Hospitals in Developing Countries. A Manual for Doctors and Other Senior Health Workers. World Health Organization: Programme for the Control of Acute Respiratory Infections. Geneva, Switzerland: 1990.
Puumalainen T, Quiambao B, Abucejo-Ladesma E, Lupisan S, Heiskanen-Kosma T, Ruutu P, et al. Clinical case review: a method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization defition for pneumonia. BMC Infect Dis. 2008;8:95.
Wilkins TR, Wilkins RL. Clinical and radiographic evidence of pneumonia. Radiol Technol. 2005;77:106–110.
Mahabee-Gittens EM, Grupp-Phelan J, Brody AS, Donnelly LF, Bracey SE, Duma EM, et al. Identifying children with pneumonia in the emergency department. Clin Pediatr. 2005;44:427–435.
Fontoura M-SH, Araújo-Neto CA, Andrade SC, Brim RV, Matutino AR, Silva CC, et al. Clinical failure among children with non-severe community-acquired pneumonia treated with amoxicillin. Expert Opin Pharmacother. 2010;11:1451–1458.
El-Radhi AS, Barry W. Thermometry in paediatric practice. Arch Dis Child. 2006;91:351–356.
World Health Organization. Integrated management of childhood illness chart booklet. (WC 503.2). Geneva: WHO, 2008. Available at: http://whqlibdoc.who.int/publications/2008/9789241597289_eng.pdf. Accessed on January 15; 2009.
Cherian T, Mulholland EK, Carlin JB, Ostensen H, Amin R, Campo M, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83:353–359.
Sazawal S, Black RE, Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a metaanalysis of community-based trials. Lancet Infect Dis. 2003;3:547–556.
Shah S, Bachur R, Kim D, Neuman MI. Lack of predictive value of tachypnea in the diagnosis of pneumonia in children. Pediatr Infect Dis J. 2010;29:406–409.
Hazir T, Qazi SA, Bin Nisar Y, Maqbool S, Asghar R, Iqbal I, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2–59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child. 2007;92:291–297.
Harari M, Shann F, Spooner V, Meisner S, Carney M, de Campo J. Clinical signs of pneumonia in children. Lancet. 1991;338:928–930.
Mulholland EK, Simoes EA, Costales MO, McGrath EJ, Manalac EM, Gove S. Standardized diagnosis of pneumonia in developing countries. Pediatr Infect Dis J. 1992;11:77–81.
Singhi S, Dhawan A, Kataria S, Walia BN. Validity of clinical signs for the identification of pneumonia in children. Ann Trop Paediatr. 1994;14:53–58.
Redd SC, Vreuls R, Metsing M, Mohobane PH, Patrick E, Moteetee M. Clinical signs of pneumonia in children attending a hospital outpatient department in Lesotho. Bull World Health Organ. 1994;72:113–118.
Falade AG, Tschäppeler H, Greenwood BM, Mulholland EK. Use of simple clinical signs to predict pneumonia in young Gambian children: the influence of malnutrition. Bull World Health Organ. 1995;73:299–304.
Graham SM, English M, Hazir T, Enarson P, Duke T. Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings. Bull World Health Organ. 2008;86:349–355.
Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010;125:342–349.
Cardoso MR, Nascimento-Carvalho CM, Ferrero F, Alves FM, Cousens SN. Adding fever to World Health Organization criteria for diagnosing pneumonia enhances the ability to identify pneumonia cases among wheezing children. Arch Dis Child. 2011;96:58–61.
Grant GB, Campbell H, Dowell SF, Graham SM, Klugman KP, Mulholland EK, et al. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis. 2009;9:185–196.
Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet. 2002;360:835–841.
Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD, et al. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ. 2004;328:791–797.
Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe communityacquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2008;(2):CD005976.
Nascimento-Carvalho CM, Souza-Marques HH. Recommendation of the Brazilian Society of Pediatrics for antibiotic therapy in children and adolescents with community-acquired pneumonia. Pan Am J Public Health. 2004;15:380–387.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Fontoura, M.S.H., Matutino, A.R., Silva, C.C. et al. Differences in evolution of children with non-severe acute lower respiratory tract infection with and without radiographically diagnosed pneumonia. Indian Pediatr 49, 363–369 (2012). https://doi.org/10.1007/s13312-012-0085-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-012-0085-6